Urothelial Cancers
Here below, you will find a list of all the latest content published on this website on the topic of Urothelial Cancers. The content is published in chronological order. Find out more about our content categorisation .
-
« Previous
- 1
- 2
- ...
- 11
-
Next »
- JVDF Trial Results Reported For Ramucirumab Plus Pembrolizumab
- Bladder and Renal Cell Cancer
- KEYNOTE Results Show Pembrolizumab Activity For Advanced Urothelial, Ovarian Cancers
- Treatment of bladder cancer
- ESMO Summit Africa 2019
- Practice changing studies in Bladder and Kidney Cancers in 2018
- Case Presentation in Bladder or Kidney Cancers
- Standards of Care and development of new targets in Bladder and Kidney Cancers
- Advanced Urinary Cancer (Renal and Bladder)
- ESMO Preceptorship on Metastatic Bladder and Kidney Cancer Zurich November 2018
- Participants Clinical Case Discussion: A Case of Toxicity in Bladder Cancer Treated with Immuno-therapy
- Debate: No, Systemic Chemotherapy is Not the Standard for Metastatic Urothelial Cancer
- Debate: Yes, Systemic Chemotherapy is the Standard for Metastatic Urothelial Cancer
- Metastatic Bladder Cancer: Immunotherapy
- Metastatic Bladder Cancer: Chemotherapy
- Radiotherapy in Metastatic Urothelial Cancer and RCC
- RCC: Surgery in Metastatic Disease
- The Role of Surgery in Metastatic Bladder Cancer
- The Search for Biomarkers in Bladder Cancer
- 10th European Multidisciplinary congress on Urological Cancers
- ESMO Preceptorship on Metastatic Bladder and Kidney Cancer Singapore September 2018
- Bladder and Renal Cell Cancer
- Congress Highlights 1 - Genitourinary tumours, non-prostate
- Neo-adjuvant ipilimumab and nivolumab in high risk resectable bladder urothelial cancer (NABUCCO)
- ATLAS: a phase 2, open-label study of rucaparib in patients (pts) with locally advanced (unresectable) or metastatic urothelial carcinoma
-
« Previous
- 1
- 2
- ...
- 11
-
Next »